Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Total article views   HTML views PDF downloads Totals
22,515 Dovepress* 12,502+ 2,208 14,710
PubMed Central* 10,013 869 10,882
Totals 22,515 3,077 25,592
*Since 20 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar